High-cost Gilead cell therapy proves durable for some lymphoma patients
By Deena Beasley SAN DIEGO: Nearly 40 percent of lymphoma patients treated with a single infusion of Gilead Sciences Inc’s Yescarta were still responding to the cell therapy after at…
Chandigarh: Government suspends licence of 1,000 chemists in 10 months
Chandigarh: In its fight against drugs, the Punjab government has tightened the noose around chemists indulging in malpractices by suspending licences of nearly 1,000 shops in the last 10 months.…
MoH To Amend Law To Regulate Brand Names To Avoid Confusion Over LASA Medications
New Delhi :The Central Drugs Standards Control Organisation (CDSCO) is likely to amend the Drugs and Cosmetics Rules to include a provision for regulating brand names. The Drug Technical Advisory…
HC Raps Delhi Govt Over Lack Of Steps To Regulate Illegal Labs
NEW DELHI:The Delhi high court ticked off the Aam Aadmi Party (AAP) government in the national capital on Friday for not taking any steps to regulate the pathological laboratories and…
State Government soon be approached by the Nagaland Pharmacy Council demanding immediate intervention of the Licences to unqualified people to run pharmacies
Unqualified People are running pharmacy shops freely in the state and now NSPC (Nagaland State Pharmacy Council) is serious regarding the issue and soon will contact the state government Chief…
Bayer to cut 12,000 jobs after Monsanto takeover
BERLIN: German chemical and pharmaceutical giant Bayer said Thursday it would slash 12,000 jobs in a major restructuring following the mammoth takeover of Monsanto, enabling it to save 2.6 billion…
Jubilant Life arm inks pact to acquire Inipharm Inc for around USD 28.5 mn
NEW DELHI: Drug firm Jubilant Life Sciences Thursday said its subsidiary Drug Discovery and Development Solutions Ltd (DDDSL) Singapore has entered into an agreement to acquire 10 per cent stake…
Jan Aushadhi shops can replace branded drugs with generics
NEW DELHI: To promote low-cost generic medicines, the government’s top drug regulatory board has allowed Jan Aushadhi Kendras — which are like fair price shops for medicines under the Pradhan…
FDA approves first biosimilar to Roche cancer drug Rituxan
Celltrion Inc’s Truxima on Wednesday became the first biosimilar to Roche Holding AG’s $7-billion-per-year cancer drug Rituxan to be approved in the United States to treat non-Hodgkin’s lymphoma. The approval…
Govt Plans Database Of Drugs To Prevent Use Of Similar Brand Names
New Delhi : The government is considering a databank for all medicine brands to prevent pharmaceutical companies from using the same or similar looking and sounding brand names for drugs, especially…
